Literature DB >> 6094746

A role for bombesin in sensory processing in the spinal cord.

T L O'Donohue, V J Massari, C J Pazoles, B M Chronwall, C W Shults, R Quirion, T N Chase, T W Moody.   

Abstract

Bombesin (BN)-containing neuronal processes were demonstrated in laminae I and II of the dorsal horn of the cat, rat, and mouse spinal cord by immunocytochemistry and radioimmunoassay. Dorsal rhizotomy in the cat resulted in a marked decrease in BN immunoreactivity in the dorsal horn indicating that BN is contained in primary sensory afferents. BN-binding sites were also localized in superficial laminae of the dorsal horn. The presence of both BN and BN-binding sites in the dorsal horn suggested that BN may be involved in sensory processing in the spinal cord. Consistent with this hypothesis, it was demonstrated that an injection of BN into the spinal cord caused a biting and scratching response indicative of sensory stimulation. The effect was similar to that observed after injection of substance P into the cord with the exception that the BN effect lasted about 100 times longer than that induced by substance P. Taken together, these data indicate that BN may be a neurotransmitter of primary sensory afferents to the spinal cord.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6094746      PMCID: PMC6564867     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  9 in total

1.  Characterization of scratching responses in rats following centrally administered morphine or bombesin.

Authors:  H Lee; N N Naughton; J H Woods; M C H Ko
Journal:  Behav Pharmacol       Date:  2003-11       Impact factor: 2.293

2.  A nociceptive signaling role for neuromedin B.

Authors:  Santosh K Mishra; Sarah Holzman; Mark A Hoon
Journal:  J Neurosci       Date:  2012-06-20       Impact factor: 6.167

3.  The role of central gastrin-releasing peptide and neuromedin B receptors in the modulation of scratching behavior in rats.

Authors:  Pin-Yen Su; Mei-Chuan Ko
Journal:  J Pharmacol Exp Ther       Date:  2011-03-18       Impact factor: 4.030

4.  Localization of gastrin-releasing peptide (GRP)-like immunoreactivity in the lysosomal compartment of the trigeminal ganglion cells of the rat.

Authors:  M Watanabe; H Kominami; N Yanaihara; H Kondo
Journal:  Histochemistry       Date:  1992

5.  The effects of substance P analogues on the scratching, biting and licking response induced by intrathecal injection of N-methyl-D-aspartate in mice.

Authors:  T Sakurada; Y Manome; K Tan-No; S Sakurada; K Kisara
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

6.  Cross-inhibition of NMBR and GRPR signaling maintains normal histaminergic itch transmission.

Authors:  Zhong-Qiu Zhao; Li Wan; Xian-Yu Liu; Fu-Quan Huo; Hui Li; Devin M Barry; Stephanie Krieger; Seungil Kim; Zhong-Chun Liu; Jinbin Xu; Buck E Rogers; Yun-Qing Li; Zhou-Feng Chen
Journal:  J Neurosci       Date:  2014-09-10       Impact factor: 6.167

7.  Descending control of itch transmission by the serotonergic system via 5-HT1A-facilitated GRP-GRPR signaling.

Authors:  Zhong-Qiu Zhao; Xian-Yu Liu; Joseph Jeffry; W K Ajith Karunarathne; Jin-Lian Li; Admire Munanairi; Xuan-Yi Zhou; Hui Li; Yan-Gang Sun; Li Wan; Zhen-Yu Wu; Seungil Kim; Fu-Quan Huo; Ping Mo; Devin M Barry; Chun-Kui Zhang; Ji-Young Kim; N Gautam; Kenneth J Renner; Yun-Qing Li; Zhou-Feng Chen
Journal:  Neuron       Date:  2014-10-30       Impact factor: 17.173

8.  B-type natriuretic peptide is neither itch-specific nor functions upstream of the GRP-GRPR signaling pathway.

Authors:  Xian-Yu Liu; Li Wan; Fu-Quan Huo; Devin M Barry; Hui Li; Zhong-Qiu Zhao; Zhou-Feng Chen
Journal:  Mol Pain       Date:  2014-01-18       Impact factor: 3.395

9.  Critical evaluation of the expression of gastrin-releasing peptide in dorsal root ganglia and spinal cord.

Authors:  Devin M Barry; Hui Li; Xian-Yu Liu; Kai-Feng Shen; Xue-Ting Liu; Zhen-Yu Wu; Admire Munanairi; Xiao-Jun Chen; Jun Yin; Yan-Gang Sun; Yun-Qing Li; Zhou-Feng Chen
Journal:  Mol Pain       Date:  2016-04-11       Impact factor: 3.370

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.